Codice QR

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma

Background: The predictive value of tumor-infiltrating lymphocytes (TILs) in immune-related adverse event (irAE) development remains unknown, although an association between tumor immunogenicity and irAEs has been suggested. We investigated the association between TIL abundance in pretreatment prima...

Descrizione completa

Salvato in:
Autori principali: I.A.J. van Duin, M. Schuiveling, L.S. ter Maat, M. Veta, M.J.M. van Eijs, R.J. Verheijden, F.W.P.J. van den Berkmortel, M.J. Boers-Sonderen, G.A.P. Hospers, M. Labots, J.W.B. de Groot, E. Kapiteijn, D. Piersma, G. Vreugdenhil, H. Westgeest, A.M.R. Schrader, P.J. van Diest, W.A.M. Blokx, K.P.M. Suijkerbuijk
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2024-12-01
Serie:Immuno-Oncology and Technology
Soggetti:
melanoma
immunotherapy
immune-related adverse events
pathology
tumor-infiltrating lymphocytes
Accesso online:http://www.sciencedirect.com/science/article/pii/S259001882400011X
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi